Strikingly, when we interrogated the Broad Institute depository (DepMap) of genome-wide RNAi screens, we noted SS is the most sensitive cancer to RNF4 silencing among 30 subtypes of cancer (Fig. 2J), consistent with the effects of silencing SUMO components in SS (Fig. 1F). The gene discussed is RNF4; the disease is cancer.